UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038709
Receipt number R000044132
Scientific Title A multicenter, prospective feasibility study for definite diagnosis of malignant pleural mesothelioma by pleural effusion cytopathology
Date of disclosure of the study information 2019/11/28
Last modified on 2020/01/24 15:41:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

MesoCyto Study

Acronym

MesoCyto Study

Scientific Title

A multicenter, prospective feasibility study for definite diagnosis of malignant pleural mesothelioma by pleural effusion cytopathology

Scientific Title:Acronym

Definite Diagnosis of Mesothelioma by Pleural Effusion Cytopathology

Region

Japan


Condition

Condition

Malignant Pleural Mesothelioma

Classification by specialty

Pneumology Chest surgery Laboratory medicine
Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to investigate the feasibility of difinite diagnosis with malignant pleural mesothelioma through cytopathology.

Basic objectives2

Others

Basic objectives -Others

none

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Diagnostic specificity of pleural effusion examination

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

99 years-old >=

Gender

Male and Female

Key inclusion criteria

1)untreated
2)supicious with malignant pleural mesothelioma based on radiological findings
3)pleural effusion examination and pleural biopsy are needed to obtain definitive diagnosis
4)pleurocentesis could be safety done
5)pleural biopsy under general anesthesia could be safety done
6)adult
7)written informed concent of this study

Key exclusion criteria

1)pleural biopsy was already done prior to this study
2)complicated other malignancies
3)complicated other intrathoracic disease(empyema, pleuritis)

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Seiki
Middle name
Last name Hasegawa

Organization

Hyogo College of Medicine

Division name

Department of Thoracic Surgery

Zip code

6638501

Address

1-1 Mukogawa-cho, Nishinomiya, Hyogo

TEL

0798-45-6885

Email

hasegawa@hyo-med.ac.jp


Public contact

Name of contact person

1st name Masaki
Middle name
Last name Hashimoto

Organization

Hyogo College of Medicine

Division name

Department of Thoracic Surgery

Zip code

6638501

Address

1-1 Mukogawa-cho, Nishinomiya, Hyogo

TEL

0798-45-6885

Homepage URL


Email

kogekogemasaki@gmail.com


Sponsor or person

Institute

Hyogo College of Medicine

Institute

Department

Personal name



Funding Source

Organization

Hyogo College of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Fukuoka University, University of Occupational and Environmental Health

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hyogo College of Medicine

Address

1-1 Mukogawa-cho, Nishinomiya, Hyogo, 6638501 Japan

Tel

0798-45-6885

Email

kogekogemasaki@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 11 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 11 Month 28 Day

Date of IRB

2019 Year 11 Month 27 Day

Anticipated trial start date

2019 Year 12 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry

2023 Year 03 Month 31 Day

Date trial data considered complete

2023 Year 06 Month 30 Day

Date analysis concluded

2023 Year 06 Month 30 Day


Other

Other related information

To compare between result of pleural effusion examination and result of pleural biopsy


Management information

Registered date

2019 Year 11 Month 28 Day

Last modified on

2020 Year 01 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044132


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name